This may or may not include tapering off a GLP-1
Methods Medline, Cochrane Library, and Scopus were queried through December 2024 for primary and secondary analyses of randomized controlled trials comparing GLP-1RA with placebo in HF patients
Zepbound (tirzepatide) is a dual GLP-1 and GIP receptor agonist approved for weight loss, and clinical trials show that gastrointestinal symptomsincluding heartburn and acid refluxoccur in 20-30% of users
10.1038/s41582-018-0032-9 Nat
Your doctor can also evaluate your diet and other stress levels, and be sure there is not another cause for hair loss, such as altered thyroid levels, polycystic ovary syndrome, or iron deficiency
Sulforhodamine B colorimetric assay for cytotoxicity screening